You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Dow
Colorcon
Medtronic
Moodys
Boehringer Ingelheim
Johnson and Johnson

Last Updated: August 9, 2020

DrugPatentWatch Database Preview

MIDODRINE HYDROCHLORIDE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Midodrine Hydrochloride, and what generic alternatives are available?

Midodrine Hydrochloride is a drug marketed by Apotex, Chartwell Rx, Impax Pharms, Mylan Pharms Inc, Par Pharm Inc, Rubicon, and Unique Pharm Labs. and is included in seven NDAs.

The generic ingredient in MIDODRINE HYDROCHLORIDE is midodrine hydrochloride. There are thirteen drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the midodrine hydrochloride profile page.

US ANDA Litigation and Generic Entry Outlook for Midodrine Hydrochloride

A generic version of MIDODRINE HYDROCHLORIDE was approved as midodrine hydrochloride by MYLAN PHARMS INC on September 10th, 2003.

  Start Trial

Drug patent expirations by year for MIDODRINE HYDROCHLORIDE
Recent Clinical Trials for MIDODRINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Bürgerspital SolothurnPhase 4
Mansoura UniversityN/A
University of California, Los AngelesEarly Phase 1

See all MIDODRINE HYDROCHLORIDE clinical trials

Pharmacology for MIDODRINE HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for MIDODRINE HYDROCHLORIDE

US Patents and Regulatory Information for MIDODRINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex MIDODRINE HYDROCHLORIDE midodrine hydrochloride TABLET;ORAL 077746-001 Sep 12, 2006 AB RX No No   Start Trial   Start Trial   Start Trial
Rubicon MIDODRINE HYDROCHLORIDE midodrine hydrochloride TABLET;ORAL 212543-003 Aug 19, 2019 AB RX No No   Start Trial   Start Trial   Start Trial
Impax Pharms MIDODRINE HYDROCHLORIDE midodrine hydrochloride TABLET;ORAL 076449-001 May 27, 2004 AB RX No No   Start Trial   Start Trial   Start Trial
Chartwell Rx MIDODRINE HYDROCHLORIDE midodrine hydrochloride TABLET;ORAL 076514-001 Sep 11, 2003 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
AstraZeneca
Baxter
Boehringer Ingelheim
Express Scripts
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.